Is Vertex Pharmaceuticals Incorporated (VRTX) a Buy, Sell, or Hold?
NASDAQ : VRTX
Vertex Pharmaceuticals Incorporated — Analyst Ratings
$477.36 USD
$4.27 (0.9%)
- Volume
- 1.25M
- Average Volume
- 1.52M
- Market Capitalization
- $121.16B
- P/E Ratio
- 28.06
- Dividend Yield
- 0.00%
- Price Target
- $576.00
- Year High
- $533.67
- Year Low
- $362.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.02
Analyst Consensus Summary
Consensus Rating
Buy
56 Analysts
Rating Score
4/5
Recommendation Strength
Upside/Downside
-17.1%
vs Current Price
Price Target
$576.00
Average TargetPrice Target Range
Lowest Target
$350.00
36.4% UPSIDE
Average Target
$576.00
Median Estimate
Highest Target
$616.00
-22.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 56
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 48 | 7 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Truist Financial | Danielle Brill | $542 | $435.93 | 2026-05-27 01:02 AM | 24.3% |
| RBC Capital | Brian Abrahams | $543 | $429.85 | 2026-05-05 07:45 AM | 26.3% |